US Patent Issued to ELANCO TIERGESUNDHEIT on April 14 for "Monoclonal antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,792, issued on April 14, was assigned to ELANCO TIERGESUNDHEIT AG (Basel, Switzerland). "Monoclonal antibodies and methods of use" was inv... Read More

US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Chimeric antigen receptors with MAGE-A4 specificity and uses thereof" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,793, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Chimeric antigen receptors with MAGE-A4 specif... Read More

US Patent Issued to ABDERA THERAPEUTICS on April 14 for "5T4 binding polypeptides and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,794, issued on April 14, was assigned to ABDERA THERAPEUTICS INC. (South San Francisco, Calif.). "5T4 binding polypeptides and uses thereo... Read More

US Patent Issued to MEDICOVESTOR on April 14 for "Oligomeric IgG for immunotherapeutics and diagnostics" (Delaware Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,795, issued on April 14, was assigned to MEDICOVESTOR INC. (Wilmington, Del.). "Oligomeric IgG for immunotherapeutics and diagnostics" was... Read More

US Patent Issued to Carisma Therapeutics on April 14 for "Constructs for chimeric antigen receptors" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,796, issued on April 14, was assigned to Carisma Therapeutics Inc. (Philadelphia). "Constructs for chimeric antigen receptors" was invente... Read More

US Patent Issued to RIN INSTITUTE, NATIONAL CANCER CENTER on April 14 for "Fibrin-binding antibody and pharmaceutical composition containing antibody" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,797, issued on April 14, was assigned to RIN INSTITUTE INC. (Tokyo) and NATIONAL CANCER CENTER (Tokyo). "Fibrin-binding antibody and pharm... Read More

US Patent Issued to Public University Corporation Nara Medical University, Chugai Seiyaku on April 14 for "Medicinal composition usable for preventing and/or treating blood coagulation factor IX abnormality, comprising multispecific antigen binding molecule replacing function of blood coagulation factor VIII" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,798, issued on April 14, was assigned to Public University Corporation Nara Medical University (Nara, Japan) and Chugai Seiyaku K.K. (Tokyo... Read More

US Patent Issued to MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN on April 14 for "Anti-IgG nanobodies" (German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,799, issued on April 14, was assigned to MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (Munich). "Anti-IgG nanobodies" was... Read More

US Patent Issued to Children's Medical Center, Beth Israel Deaconess Medical Center on April 14 for "Therapeutic use of mitochondria and combined mitochondrial agents" (Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,800, issued on April 14, was assigned to Children's Medical Center Corp. (Boston) and Beth Israel Deaconess Medical Center Inc. (Boston). ... Read More

US Patent Issued to Fred Hutchinson Cancer Center on April 14 for "Single-domain antibodies that bind ROR1" (Washington Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,801, issued on April 14, was assigned to Fred Hutchinson Cancer Center (Seattle). "Single-domain antibodies that bind ROR1" was invented b... Read More

• ««
• «
• 9612
• 9613
• 9614
• 9615
• 9616
• 9617
• 9618
• 9619
• 9620
• 9621
• »
• »»